WCM26: Reshaping the Routine With JAK Inhibition in Vitiligo Care: An Online Activity

Released on
March 30, 2026
Earn up to
0.5 AMA PRA Category 1 Credit™
Catch all of the highlights on clinical data updates and case-based management tips on JAK inhibitors in vitiligo from our Winter Clinical meetings in Hawaii and Miami!
“We’ve come such a long way with JAK inhibitors, and it is really the standard of care at this point… So this is such an exciting time and hopeful time for these patients, because quality of life is severely impacted.” - Susan Taylor, MD
WCM26: Reshaping the Routine With JAK Inhibition in Vitiligo Care: An Online Activity
This activity is supported by educational grants from AbbVie and Incyte.